SCHEMBL20176684

SCHEMBL20176684

Brc1ccc(-c2c3ccccc3c(-c3ccc(-c4cccc5ccccc45)cc3)c3ccccc23)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
ENPP1 P22413 2/20 0.42
ENPP3 O14638 1/20 0.42
CA12 O43570 4/20 0.42
CA9 Q16790 4/20 0.42
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
TNF P01375 1/20 0.41
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA7 P36544 1/20 0.38
PRKCZ Q05513 1/20 0.37
PPARG P37231 5/20 0.37
PPARA Q07869 5/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
PPARD Q03181 1/20 0.37
MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29776190 1.00 HDAC8 (0.44) HDAC8HDAC6L3MBTL1ENPP1ENPP3
SCHEMBL15158457 0.92 L3MBTL1 (0.44) HDAC8HDAC6L3MBTL1ENPP1ENPP3
SCHEMBL24446252 0.83 CA12 (0.55) HDAC8HDAC6ENPP1ENPP3CA12
SCHEMBL2252435 0.82 HDAC8 (0.50) HDAC8HDAC6ENPP1ENPP3CA12
SCHEMBL29658013 0.82 HDAC8 (0.50) HDAC8HDAC6ENPP1ENPP3CA12
SCHEMBL28491556 0.82 HDAC8 (0.50) HDAC8HDAC6ENPP1ENPP3CA12
SCHEMBL29658012 0.82 HDAC8 (0.50) HDAC8HDAC6ENPP1ENPP3CA12
SCHEMBL25210264 0.81 L3MBTL1 (0.46) L3MBTL1CYP2C9CYP2C19CYP1A2
SCHEMBL20176553 0.81 L3MBTL1 (0.42) L3MBTL1TNF
SCHEMBL29776272 0.81 L3MBTL1 (0.42) L3MBTL1TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
CN-110023305-B Organic light-emitting compound and organic electroluminescent element using same 索路思高新材料有限公司 2022-08-09 CN disclosed
WO-2018093231-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME 주식회사 두산 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same OR10J3, ICMT, SLCO4C1 HDAC8 4586/4885HDAC6 4618/4885L3MBTL1 869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.